Article
IOP-lowering drug a versatile choice in large-scale study
Houston-Once-daily bimatoprost 0.03% (Lumigan, Allergan) is a highly effective, safe, and well-accepted IOP-lowering medication across the di-verse population of patients encountered in daily practice, according to the results of a large-scale, com-munity-based, pro-spective, open-label study.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
